IM Cannabis Accounts Payable

IM Cannabis (IMCC) currently reports a accounts payable of $8.2M as of March 2026. That compares with $16M in the prior-year period — down 48.9% year over year. Use the charts on this page to explore IM Cannabis's accounts payable history and peer comparisons.

IM Cannabis's accounts payable decreased from $16M to $8.2M — a 48.9% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IM Cannabis reported $8.2M in accounts payable as of March 2026. That compares with $16M in the prior-year period — down 48.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $8.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for IM Cannabis, and consider following IMCC for alerts when major investors trade the stock.

IM Cannabis is classified in the Healthcare sector. On accounts payable, it currently shows $8.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMCC with unrelated industries.